- Hong Kong
- /
- Healthcare Services
- /
- SEHK:1931
IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297
IVD Medical Holding Limited (HKG:1931) will increase its dividend from last year's comparable payment on the 6th of September to CN¥0.0297. This will take the dividend yield to an attractive 6.1%, providing a nice boost to shareholder returns.
See our latest analysis for IVD Medical Holding
IVD Medical Holding's Earnings Easily Cover The Distributions
Impressive dividend yields are good, but this doesn't matter much if the payments can't be sustained. Based on the last payment, IVD Medical Holding was quite comfortably earning enough to cover the dividend. This means that a large portion of its earnings are being retained to grow the business.
Unless the company can turn things around, EPS could fall by 1.6% over the next year. If the dividend continues along recent trends, we estimate the payout ratio could be 50%, which we consider to be quite comfortable, with most of the company's earnings left over to grow the business in the future.
IVD Medical Holding's Dividend Has Lacked Consistency
Even in its short history, we have seen the dividend cut. The dividend has gone from an annual total of CN¥0.0479 in 2020 to the most recent total annual payment of CN¥0.072. This means that it has been growing its distributions at 15% per annum over that time. IVD Medical Holding has grown distributions at a rapid rate despite cutting the dividend at least once in the past. Companies that cut once often cut again, so we would be cautious about buying this stock solely for the dividend income.
IVD Medical Holding May Find It Hard To Grow The Dividend
With a relatively unstable dividend, it's even more important to see if earnings per share is growing. Although it's important to note that IVD Medical Holding's earnings per share has basically not grown from where it was five years ago, which could erode the purchasing power of the dividend over time.
In Summary
Overall, this is probably not a great income stock, even though the dividend is being raised at the moment. The payments haven't been particularly stable and we don't see huge growth potential, but with the dividend well covered by cash flows it could prove to be reliable over the short term. We would be a touch cautious of relying on this stock primarily for the dividend income.
Market movements attest to how highly valued a consistent dividend policy is compared to one which is more unpredictable. At the same time, there are other factors our readers should be conscious of before pouring capital into a stock. For example, we've picked out 2 warning signs for IVD Medical Holding that investors should know about before committing capital to this stock. Is IVD Medical Holding not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:1931
IVD Medical Holding
An investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally.
Solid track record with excellent balance sheet.